-
1
-
2
-
3
677 Lower risk of cardiovascular (CV) events and death in men receiving ADT by gonadotropin releasing hormone (GnRH) antagonist, degarelix, compared with luteinising hormone-releas...
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
4
-
5
139 EVALUATION OF THE EFFICACY AND SAFETY OF SWITCHING FROM TREATMENT WITH LEUPROLIDE 1-MONTH DOSING REGIMEN TO DEGARELIX 1-MONTH DOSING REGIMEN IN PROSTATE CANCER (PCA) PATIENTS
Veröffentlicht in European urology supplements : official journal of the European Association of Urology
VolltextArtikel -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Factors influencing prognosis for occupational hand eczema
Veröffentlicht in British journal of dermatology (1951)
VolltextArtikel -
19
-
20